Lymphatic Drainage Specialists Informed Consent FAQ
This FAQ collects the questions manual lymphatic drainage specialists actually ask about informed consent and intake forms: MLD versus CDT distinction, the four primary recognized methods (Vodder, Foldi, Casley-Smith, Klose), the LANA-CLT credential, surgeon-released scope for post-cosmetic-surgery clients (BBL, liposuction, abdominoplasty), lymphedema versus cosmetic edema scope, ISL staging acknowledgment, MLD contraindications including DVT and CHF and active malignancy without medical clearance, HIPAA scope for medical-billing scenarios, BAA requirements, compression bandaging scope, and audit trail posture. Each answer is self-contained and citation-backed. If you need a workflow that drafts the consent, captures the e-signature, and produces a HIPAA-aligned audit trail in one place, Formfy is the AI form builder MLD practitioners use; see /guides/how-to-create-mld-informed-consent-lymphatic-drainage-specialists for the ten-step companion guide.
Statistics referenced: the Lymphology Association of North America (LANA) administers the recognized voluntary North American Certified Lymphedema Therapist credential. The four primary recognized MLD methods (Vodder, Foldi, Casley-Smith, Klose) trace back to founders dating from the 1930s through the late twentieth century. The International Society of Lymphology (ISL) publishes the recognized clinical staging system. Active state-licensed massage therapists are estimated in the 250,000-plus range across the United States; LANA-CLT-credentialed therapists represent a smaller specialized subset. Post-cosmetic-surgery MLD demand has grown substantially with the volume of body-contouring procedures performed annually.
Frequently Asked Questions
MLD informed consent FAQ
What is the difference between basic MLD and Complete Decongestive Therapy (CDT)?
Manual Lymphatic Drainage (MLD) at the basic level is a specific manual technique to support lymph flow; basic MLD can be performed by a Licensed Massage Therapist with documented MLD training. Complete Decongestive Therapy (CDT) is a four-component clinical protocol consisting of MLD plus compression bandaging plus exercise plus skin care, used for lymphedema management. CDT typically requires Lymphology Association of North America Certified Lymphedema Therapist (LANA-CLT) credentialing, which has medical-professional prerequisites such as PT, OT, MD, DO, DC, RN, MT, or LMT depending on the program. State the scope clearly on the consent so the client understands which protocol the practice offers. Misrepresenting basic MLD as CDT exposes the practitioner to state-board complaints and patient harm.
What are the four primary recognized MLD methods?
MLD is taught in four primary recognized methods. The Vodder Method, developed by Emil and Estrid Vodder in the 1930s, is the original MLD technique with a long international training tradition. The Foldi Method, developed by Michael and Ethel Foldi, is the European clinical-medicine standard, particularly for CDT and lymphedema management. The Casley-Smith Method, developed by Judith and John Casley-Smith, is widely taught in Australia and globally with research backing. The Klose Method, developed by Guenter Klose, is widely used in the United States, particularly for post-cosmetic-surgery and oncology contexts. State the practitioner training method, school, and documented hours on the consent so the client understands the technique foundation. Method acknowledgment supports informed consumer choice.
What does the LANA-CLT credential require?
The Lymphology Association of North America Certified Lymphedema Therapist (LANA-CLT) is the recognized voluntary North American credential for clinical lymphedema management. Candidates must hold a qualifying healthcare license (PT, OT, MD, DO, DC, RN, MT, or LMT depending on the program), complete an approved 135-hour training program in CDT, document supervised clinical hours, and pass the LANA written examination. Continuing education is required for renewal. LANA-CLT is the credential most commonly required by hospitals, lymphedema clinics, and insurance-billing programs. State the practitioner LANA-CLT status on the consent: certified, in-process, or not pursuing. Acknowledging credentials honestly is an ethics requirement and aligns with FTC truth-in-advertising guidance.
When is MLD safe for post-cosmetic-surgery clients (BBL, lipo, abdominoplasty)?
MLD is safe for post-cosmetic-surgery clients only on a surgeon-released basis. The practice does not provide MLD for any post-cosmetic-surgery client without documented release from the operating surgeon stating: the patient is cleared for soft-tissue work in specified areas, the surgical sites are healed sufficiently to tolerate manual contact, the patient has met the surgeons benchmarks for activity and compression-garment use, drains have been removed where applicable, and there are no remaining contraindications such as open incisions, infections, or anticoagulant therapy. Capture the release in the patient record before the first session and re-confirm before any session that follows new symptoms. Most post-cosmetic-surgery MLD malpractice claims trace to sessions delivered before adequate clearance. State the requirement clearly on the consent.
What is the difference between lymphedema and cosmetic edema?
Lymphedema is a clinical condition caused by lymphatic system dysfunction, often arising post-surgical (lymph node removal during cancer treatment), post-radiation (radiation damage to lymphatic structures), or congenital. Lymphedema is a chronic medical condition managed with CDT under medical supervision. Cosmetic edema refers to the temporary swelling that follows cosmetic surgery and resolves naturally as healing progresses; basic MLD may support comfort and recovery in this window. State the scope clearly on the consent: practitioners offering only basic MLD must not market or describe their work as lymphedema management. Practitioners offering CDT for lymphedema must hold the LANA-CLT or equivalent credential and typically work under physician supervision. Misrepresenting cosmetic-edema work as lymphedema management is a leading source of state-board and FTC concerns.
When does HIPAA apply to an MLD practice?
HIPAA applies when the MLD practice is a covered entity under 45 CFR 160.103. Most basic MLD practitioners are not HIPAA-covered because they do not bill insurance and do not transmit electronic health information in HIPAA-defined standard transactions. CDT-credentialed practitioners working under physician supervision, MLD specialists embedded in medical-billing practices, and practitioners accepting HSA or FSA cards processed electronically may be covered. State the HIPAA posture explicitly on the consent. When covered, reference 45 CFR 164.502 (Privacy Rule core uses and disclosures), provide the patient with a current Notice of Privacy Practices, and capture written acknowledgment of receipt. Even when not HIPAA-covered, applying HIPAA-equivalent privacy practices is the conservative default for clinical-MLD settings.
Which MLD contraindications are absolute and require referral?
Absolute MLD contraindications: acute infection (cellulitis, lymphangitis, untreated bacterial infections), uncontrolled congestive heart failure (CHF) because increased lymph return can overload the heart, deep vein thrombosis (DVT) within twelve months because lymphatic stimulation can dislodge clots, active malignancy without oncologist clearance because of theoretical concerns about cancer cell mobilization, acute renal failure, and pulmonary embolism history within twelve months. The practitioner refers without proceeding when any absolute contraindication is present. Require physician clearance (a separate gating step) for: post-radiation tissue, recent surgery within twelve weeks unless surgeon-released, current anticoagulant therapy, hypothyroidism, and asthma. Screen on intake, document the screen, and route any positive answer to the appropriate clearance or referral flow before the session proceeds.
What is the ISL lymphedema staging system?
The International Society of Lymphology (ISL) publishes a recognized lymphedema staging system. Stage 0 is latent (subclinical) lymphedema with reduced lymphatic transport but no visible swelling. Stage I is early reversible lymphedema with pitting edema that reduces with elevation. Stage II is spontaneously irreversible lymphedema with progressive tissue fibrosis and minimal pitting. Stage III is lymphostatic elephantiasis with severe fibrosis, papillomatosis, and skin changes. Practitioners working with lymphedema patients should acknowledge ISL staging on the consent and intake when serving staged-lymphedema patients under physician supervision. Basic MLD practitioners typically do not stage patients themselves; staging is a clinical determination by the treating physician, oncologist, or lymphedema specialist. Document the patients staged condition (per the referring physician) on intake.
Can a Licensed Massage Therapist provide MLD without specialized training?
No. MLD requires specialized training because the technique, contraindications, anatomical understanding, and clinical reasoning differ substantively from standard massage. Recognized training programs (Vodder, Foldi, Casley-Smith, Klose schools) typically run 100 to 135 hours for basic MLD certification, with longer hours required for CDT and LANA-CLT eligibility. Many state boards require documented MLD continuing education before practitioners deliver MLD professionally. State the practitioner training method, school, and hours on the consent so the client understands the technique foundation. Practitioners offering MLD without documented training expose themselves to state-board complaints, malpractice claims, and patient harm. Reflect the actual training honestly; method acknowledgment aligns with truth-in-advertising standards.
How does an MLD practice handle compression bandaging scope?
Compression bandaging is a CDT component that typically requires LANA-CLT or equivalent credentialing because incorrect bandaging can worsen lymphedema, restrict circulation, or cause skin breakdown. Basic MLD practitioners without CLT credentialing should not provide compression bandaging as a stand-alone service. Compression-garment fitting (off-the-shelf or custom-fitted) is a related but distinct scope; some MLD practitioners with appropriate training fit compression garments under physician orders, while others refer to a certified fitter or DME supplier. State the practice scope clearly on the consent: which compression services are offered, which are not, and the referral path for services outside scope. Patients with lymphedema typically require compression as a core therapy element; misrepresenting compression scope leads to clinical and regulatory issues.
How does an MLD practice screen for skin and wound contraindications?
Wounds and skin-integrity issues are absolute contraindications to MLD until cleared. Open wounds, surgical incisions before healing benchmarks, infected wounds, post-radiation skin breakdown, suspected malignant skin lesions, severe eczema or psoriasis flares, recent burns, and contagious skin conditions all contraindicate MLD. Screen on the intake form and visually inspect at each session before initiating manual contact. Document the inspection in the session record. State the wound contraindication clearly on the consent so the client understands the practice will not proceed when wounds are present. For post-cosmetic-surgery clients with healing incisions, the surgeon-released requirement addresses the timing question; the visual inspection at each session validates that the surgeon-released benchmark continues to hold.
What insurance does an MLD practitioner need?
MLD practitioners carry professional liability and general liability insurance, typically $1 million per occurrence and $3 million aggregate. Coverage is available through AMTA, ABMP, NCBTMB-sponsored carriers, and LANA-CLT-affiliated programs for credentialed practitioners. Insurance carriers commonly require documented MLD training hours, current state license, and adherence to professional codes of ethics. CDT-practicing LANA-CLT practitioners and post-cosmetic-surgery MLD specialists may carry higher limits because the patient population is higher-risk. Disclose the coverage in the consent or in the practice documentation so the client understands the practice carries appropriate liability protection. Document policy renewals annually and update consent language if the carrier requires specific disclosure. Practitioners working in clinical or hospital settings may carry specialty endorsements.
When does an MLD practice need a Business Associate Agreement?
A HIPAA-covered MLD practice must sign a Business Associate Agreement with any vendor that creates, receives, maintains, or transmits protected health information on the practice behalf. 45 CFR 164.504(e) defines BAA content requirements, and 45 CFR 164.314 imposes specific security obligations the BAA must cover. Common BAA-eligible vendors: cloud intake form platforms, electronic health records systems, secure email and SMS providers, scheduling platforms that capture intake screening, billing clearinghouses, and cloud backup services. Form builders that capture MLD intake forms with health information should be reviewed for BAA availability when the practice operates as a HIPAA-covered entity. Formfy provides BAAs for practices that need them. Confirm the BAA language covers the data flows the practice actually uses.
How is termination of MLD services handled?
MLD termination triggers include: the patient reaches treatment goals (cosmetic-edema window resolves, lymphedema reaches maintenance phase), the referring physician discontinues the treatment plan, the patient develops a contraindication during the course of care, the patient is non-compliant with the home program (compression garment wear, skin care) or scheduling, the patient requires care outside the practitioner scope (surgical intervention, oncology specialty, advanced CDT requiring LANA-CLT credential the practitioner does not hold), or the practitioner relocates or closes the practice. State the standard process on the consent: notify the patient in writing, complete any in-progress prepaid sessions, transfer records to the referring physician with written authorization, and document the termination in the record. AMTA Code of Ethics requires referral when scope is exceeded.
Are e-signed MLD consents legally enforceable?
Yes. The federal Electronic Signatures in Global and National Commerce Act (ESIGN Act, 15 USC 7001) and the Uniform Electronic Transactions Act (UETA) adopted in 49 states give electronic signatures the same legal effect as wet-ink signatures for nearly all healthcare-adjacent service contracts. MLD consent forms are squarely covered. Tools that capture a tamper-evident audit trail with timestamps, IP addresses, and consent to electronic records produce the strongest record. Formfy, DocuSign, Adobe Acrobat Sign, and Dropbox Sign all meet this evidentiary bar. State boards have broadly accepted electronic signature audit trails when they meet ESIGN Act requirements. HIPAA-covered MLD practices should confirm the e-signature platform offers a Business Associate Agreement.
How long should an MLD practice retain signed consents?
Standard retention for MLD consent and intake records is at least seven years from the last service date. HIPAA-covered practices must retain Privacy Rule documentation (Notice of Privacy Practices, BAAs, training logs, breach assessments) for six years from creation or last effective date under 45 CFR 164.530(j). State medical-records laws may impose longer retention requirements; California Confidentiality of Medical Information Act and New York Public Health Law often reach ten years for adult patients and longer for minor patients. Insurance carriers commonly require seven-to-ten-year retention as a condition of malpractice coverage. Storage must be encrypted, access-controlled, and indexed by patient name and service date. Cloud storage that produces an audit trail showing who accessed which record when supports both HIPAA and malpractice posture.
How does Formfy specifically help MLD practitioners with consent and intake?
Formfy lets an MLD practitioner describe the practice in plain English to the AI form builder, which returns a delivery-ready consent and intake form with the e-signature block, the contraindications screening, the surgeon-release documentation gate for post-cosmetic-surgery clients, the method-acknowledgment paragraph (Vodder, Foldi, Casley-Smith, or Klose), and an optional session-deposit payment field. Formfy provides a Business Associate Agreement for practices operating under HIPAA. The LANA-CLT credential disclosure, ISL staging acknowledgment for lymphedema patients, and termination-and-referral protocol are imported once and reused across every form revision. Submission-based pricing at $19 to $199 per month covers practice volumes without per-envelope penalties. The free 15-day trial requires no credit card.
Related resources
Build an MLD consent and intake in 30 seconds
Free 15-day Formfy trial. No credit card. Submission-based pricing.
Start your free trialLast verified: 2026-04-25. This page is informational; it is not legal advice. MLD practitioners should review state-specific licensing, post-cosmetic-surgery scope with surgeon counsel, and lymphedema-management scope with a LANA-CLT credentialed reviewer where applicable.